Protein Assays Market Size

Protein Assays Market Size Snapshot

Note – Market size depicts the revenue generated over the financial year

The market for the enzymatic assays is expected to grow significantly. The CAGR for the period 2025–2035 is 5.89%. The demand for protein analysis in various industries, such as pharmaceuticals, biotechnology, and food and beverage, is expected to grow. The growing interest in personalized medicine and the development of the proteomic and biomarker research is driving the need for efficient and accurate methods for the quantification of the target proteins. The growing demand for the enzymatic assays is driven by a number of factors. High-throughput screening and the development of new assays are enhancing the efficiency and accuracy of the assays. Also, the growing prevalence of chronic diseases and the increasing focus on research and development in the life sciences are expected to drive the growth of the market. The major players in the industry, such as Thermo Fisher Scientific, Bio-Rad Laboratories, and Merck KGaA, are focusing on strategic initiatives, such as product launches, collaborations, and acquisitions, to enhance their market presence and product offerings. Recent collaborations aimed at integrating advanced technologies into the enzymatic assays are expected to have a significant impact on the market in the coming years.

Regional Market Size

Regional Deep Dive

The Protein Assays Market is growing rapidly across the globe, driven by the growing research activity in biotechnology and pharmaceuticals, and the rising demand for protein quantification in clinical diagnostics. North America is leading the way in technological developments and research funding, while Europe is characterized by strict regulatory frameworks that ensure high-quality standards. The Asia-Pacific region is growing rapidly because of the expansion of the health care system and the increasing investment in life sciences, while the Middle East and Africa are slowly developing their market presence through government initiatives and collaborations. Latin America is still in its infancy, but it is growing rapidly because of the growing expenditure on health care and research.

North America

• The National Institutes of Health (NIH) has increased its support of proteomic research, resulting in a corresponding increase in the availability of assays and methodologies.
• Thermo Fisher Scientific and Bio-Rad Laboratories are innovating with high-throughput protein assays, which improve the efficiency of research laboratories.
• A change in the regulatory environment, such as the FDA’s emphasis on precision medicine, has created a need for more accurate protein quantification methods.

Europe

• The European Medicines Agency (EMEA) has tightened its regulations for the use of proteolytic assays in drug development, which will ensure a higher degree of quality and reliability.
• Merck KGaA and Roche are investing in new assays, especially in the field of multiplexing, the simultaneous measurement of several proteins.
• Horizon 2020 supports projects which aim to develop new ways of determining the quality of a protein.

Asia-Pacific

• The Chinese government's National Natural Science Foundation has backed many research projects on protein research, which has greatly enlarged the market for protein assays.
• The companies Abcam and Takara Bio have also expanded their activities in this region and are introducing advanced protein assay kits to meet local needs.
• In India and Japan the growing frequency of chronic diseases has led to a rising demand for clinical diagnostics.

MEA

• The Ministry of Health in the United Arab Emirates has been pushing for the adoption of advanced methods of protein assay.
• Universities and international biotech companies are collaborating in South Africa to develop new methods for the detection of proteins.
• The regulatory authorities of the region are beginning to establish standards for the measurement of dietary protein. This is expected to improve the quality of the market and encourage investment.

Latin America

• The National Council for Scientific and Technological Development (CNPq) has been supporting projects on the analysis of proteins, thus stimulating the market.
• Local companies are increasingly collaborating with foreign companies to produce and offer better quality and more accessible assays.
• The rising health expenditure in countries such as Mexico is leading to increased investments in the laboratory. This is driving the growth of the protein assays market.

Did You Know?

“In the development of drugs, it is of great value to determine the effectiveness of therapeutic proteins; in food hygiene, it is of great value to measure the amount of protein in a product.” — American Society for Biochemistry and Molecular Biology

Segmental Market Size

The current growth of the market for the measurement of protein is due to the growing need for accurate quantification of these molecules in various research and clinical applications. The growing number of chronic diseases requires the development of diagnostics and the increasing importance of the identification of biomarkers for individual treatment. The demand for reliable assays in the pharmaceutical and biotechnology industries is also increasing.

The market is currently at the stage of mature adoption, with the likes of Thermo Fisher Scientific and Bio-Rad Laboratories leading the way in the development of new assays. The primary application areas include drug discovery, clinical diagnostics and food safety testing. Assays are used to ensure the safety and efficacy of products. Assays are used to detect the presence of pathogens and the like. Various trends, such as the influenza pandemic, have increased the need for rapid tests. At the same time, the demand for greener methods is growing. There are a number of developments underway in the field of assays, with the likes of ELISA, mass spectrometry and microfluidics enabling more accurate and rapid results.

Future Outlook

The market for the assay of proteins is expected to reach a value of $ 10 billion by 2035, growing at a CAGR of 5.89 percent between 2024 and 2035. The growing demand for assays of proteins in the pharmaceutical, biotechnology, and food safety industries will fuel this growth. In addition, the increasing focus on health and nutrition will increase the need for accurate and efficient methods for the quantification of proteins, and the use of assays of proteins in laboratories and research institutions will increase significantly. By 2035, it is expected that more than 70 percent of research laboratories will use advanced assays of proteins in their work, thereby increasing the reliability of their research and accelerating the development of new products.

IT TECHNOLOGY - The integration of automation and artificial intelligence in the process of measuring the activity of the proteins will be a major trend in the market. These innovations will not only improve the accuracy and speed of measuring the activity of the proteins, but also reduce the costs of the tests, making them available to a wider range of users. Also, the importance of the analysis of the activity of the proteins in the field of drug development and food safety will be further increased by regulatory requirements. In addition, the growing interest in individualized medicine and the increasing occurrence of chronic diseases will lead to an increase in demand for the activity of the proteins, as the role of these macromolecules in health and disease will be further investigated. In conclusion, the market for the activity of the proteins will continue to develop dynamically, driven by technological progress and an increase in its application areas.